Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Investigational Product for Atopic Dermatitis Patients Study
Clinical Trial Protocol ID
13083002

Clinical Trial Investigator Name
Michael D. Tharp

Clinical Trial Title

A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of an Investigational Product in Atopic Dermatitis Patients Who Are Inadequately Controlled by or Intolerant to Topical Therapy



Clinical Trial Protocol Description

Rush Dermatology seeks volunteers with a diagnosis of atopic dermatitis or eczema for a clinical trial testing an investigational medication. All office visits and treatments are provided free of charge.

Anticipated results are a possible new treatment option for patients with moderate to severe atopic dermatitis.

The study will last about 24 weeks with a possible extension.



Clinical Trial Eligibility Criteria

You may be eligible to participate in this study if you:

  • Have moderate to severe atopic dermatitis or eczema
  • Are 18 to 65 years of age
  • Have had an inadequate response to at least one topical steroid or topical calcineruin inhibitor
  • Are willing to stop current treatments




Contact Name Carmen Petrizzo or Danica Uzelac
Contact Phone (312) 563-4001
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Dermatology Trials
Investigational Product for Atopic Dermatitis Patients Study

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois